NovoSeven® 2 mg


Powder and solvent for solution for injection
scheduling status
S4
registration number
44/8.1/0551
What NovoSeven® 2 mg contains
Coagulation factor VIIa (eptacog alfa).
other ingredients
Powder: Sodium chloride Calcium chloride dihydrate Glycylglycine Polysorbate 80 Mannitol Sucrose Methionine Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment). Solvent: Histidine Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment) Water for injections.
Therapeutic classification
B02BD08.
© 2026 SAHPRA. ALL RIGHTS RESERVED